An experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound.

In addition, Cognito said in Tuesday’s announcement that it plans to use the biomarker analyses to look for indicators of Alzheimer’s progression and to spot new disease areas that may also ...

Cognito Therapeutics Inc. became the latest company to secure a large-scale trial to treat Alzheimer’s disease. Unlike most other remedies in development today, this one involves a device rather ...

Just as a new wave of approved drugs for Alzheimer’s reaches patients, Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment.

Cognito Therapeutics just raised $73 million to test its headset in 500 patients with Alzheimer's disease.

Cognito finds new medical, technology heads in BrainStorm, Philips alums By Andrea Park Apr 17, 2023 11:15am Cognito Therapeutics executives chief medical officer Alzheimer's disease ...

Plaid, a fintech unicorn known for its APIs that connect consumer bank accounts to financial applications, announced today that it is buying Cognito. The ...

Cognito to Present Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety and Durability of Treatment Benefits Over 18 Months at CTAD 2023 ...

Cognito Therapeutics to Advance Digital Therapeutic for Alzheimer’s into Pivotal Studies Based on Positive Clinical Results Announced at AD/PD 2021 ...

Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline.

Ian Cognito, a British comic, fell ill during his stand-up set at the Atic bar in the English town of Bicester, 14 miles north of Oxford, according to CNN.